You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Details for Patent: 11,065,265


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,065,265 protect, and when does it expire?

Patent 11,065,265 protects FOCINVEZ and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 11,065,265
Title:Compositions of fosaprepitant and methods of preparation
Abstract:The present application and its embodiments teach stable compositions of fosaprepitant or a pharmaceutically acceptable salt thereof with such compositions lacking polysorbate 80 and containing dual functional excipients of hydrolysis inhibition and solubility enhancement. Further described are methods of preparation of such compositions. Among other advantages of contemplated compositions, fosaprepitant hydrolysis degradation is kept low and the compositions maintain physically and chemically stable for prolonged period.
Inventor(s):Yu Jianwei, Wang Yulu
Assignee:SPES PHARMACEUTICALS INC.
Application Number:US16245992
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies for their intellectual creations. The landscape of patent law is complex and constantly evolving, influenced by legislative changes, judicial interpretations, and technological advancements. This article will delve into the intricacies of patent scope and claims, using U.S. Patent 11,065,265 as a case study, and explore the broader patent landscape in the United States.

The Importance of Patent Scope and Claims

Patent scope and claims define the boundaries of what is protected under a patent. These elements are crucial for determining the validity and enforceability of a patent. The scope of a patent is essentially the range of protection it offers, while the claims are the specific descriptions of the invention that define this scope[3].

The Structure of a Patent

A patent typically includes several key sections:

  • Abstract: A brief summary of the invention.
  • Background of the Invention: Context and prior art related to the invention.
  • Summary of the Invention: A concise description of the invention.
  • Detailed Description of the Invention: An in-depth explanation of the invention, often including drawings and diagrams.
  • Claims: The most critical part, as these define the legal boundaries of the invention[4].

Understanding Patent Claims

Patent claims are the heart of a patent, as they specify what is protected. There are two main types of claims:

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to an independent claim and further limit the scope of the invention[3].

The Role of the USPTO in Patent Examination

The United States Patent and Trademark Office (USPTO) is responsible for examining patent applications to ensure that the inventions meet the criteria for patentability. This includes novelty, non-obviousness, and utility. The USPTO also maintains datasets and tools to analyze patent claims and scope, such as the Patent Claims Research Dataset, which provides detailed information on claims from U.S. patents and applications[3].

Impact of Legislative Changes on Patent Litigation

Legislative changes, such as the Leahy-Smith America Invents Act (AIA) of 2011, have significantly impacted patent litigation. The AIA introduced changes like the first-to-file system and limitations on the number of defendants in a lawsuit, which led to an increase in the number of patent infringement lawsuits. For instance, the number of overall defendants in patent infringement lawsuits increased by about 129 percent from 2007 to 2011, largely due to software-related patents[1].

Judicial Interpretations and Patent Eligibility

The judiciary plays a crucial role in shaping patent law through its interpretations. The "Alice" test, established by the Supreme Court, is a two-step process to determine whether patent claims are directed to patent-eligible subject matter. This test helps in distinguishing between abstract ideas and technological improvements. For example, in the case of Contour IP Holding LLC v. GoPro, Inc., the court applied the "Alice" test to determine whether the claims of the ’954 patent were directed to patent-eligible subject matter, emphasizing the importance of specific technological means and improvements[2].

The Rise of Nonpracticing Entities (NPEs)

Nonpracticing entities (NPEs), often referred to as "patent trolls," have become a significant factor in patent litigation. NPEs do not manufacture products but instead focus on enforcing patents through litigation. According to the GAO, NPEs brought about a fifth of all patent infringement lawsuits from 2007 to 2011, highlighting their impact on the patent landscape[1].

Advanced Patent Searching and Analysis

Advanced tools and databases, such as the USPTO's Patent Public Search and the PATENTSCOPE database, facilitate comprehensive searches of patent grants and applications worldwide. These resources are essential for conducting thorough patent searches, analyzing patent scope, and identifying potential infringement risks[4].

The Need for a Small Claims Patent Court

There has been ongoing discussion about the need for a small claims patent court to address the high costs and complexities associated with patent litigation. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on this issue, considering the feasibility and potential structure of such a court. This initiative aims to make patent litigation more accessible and affordable for smaller entities[5].

Case Study: U.S. Patent 11,065,265

While specific details of U.S. Patent 11,065,265 are not provided here, a general approach to analyzing its scope and claims would involve:

  • Reviewing the Claims: Analyze the independent and dependent claims to understand the protected invention.
  • Examining the Detailed Description: Study the detailed description and drawings to comprehend the invention's functionality and limitations.
  • Assessing Prior Art: Evaluate the background and prior art sections to understand how the invention differs from existing technologies.
  • Judicial and Legislative Context: Consider any relevant judicial interpretations or legislative changes that might affect the patent's validity or enforceability.

Key Takeaways

  • Patent Scope and Claims: These are critical for defining the legal boundaries of an invention.
  • Legislative and Judicial Impact: Changes in law and judicial interpretations significantly affect patent litigation and eligibility.
  • Role of USPTO: The USPTO plays a vital role in examining patents and maintaining datasets for analysis.
  • NPEs and Patent Litigation: Nonpracticing entities are a significant factor in patent litigation.
  • Advanced Searching Tools: Utilizing advanced databases and tools is essential for thorough patent analysis.

FAQs

What is the primary purpose of patent claims?

Patent claims define the legal boundaries of an invention, specifying what is protected under the patent.

How has the Leahy-Smith America Invents Act (AIA) impacted patent litigation?

The AIA introduced changes such as the first-to-file system and limitations on the number of defendants, leading to an increase in patent infringement lawsuits, particularly those involving software-related patents.

What is the "Alice" test, and how is it applied?

The "Alice" test is a two-step process to determine whether patent claims are directed to patent-eligible subject matter. It involves assessing whether the claims are directed to an abstract idea and, if so, whether they include elements that transform them into a patent-eligible application.

What role do nonpracticing entities (NPEs) play in patent litigation?

NPEs, or "patent trolls," do not manufacture products but focus on enforcing patents through litigation, accounting for a significant portion of patent infringement lawsuits.

Why is there a discussion about establishing a small claims patent court?

The discussion aims to address the high costs and complexities of patent litigation by making it more accessible and affordable for smaller entities.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation[1].
  2. Contour IP Holding LLC v. GoPro, Inc.: Federal Circuit Court Opinion[2].
  3. USPTO Patent Claims Research Dataset: Detailed information on claims from U.S. patents and applications[3].
  4. Clemson University Patent Searching Guide: Advanced patent searching and analysis tools[4].
  5. ACUS Study on Small Claims Patent Court: Feasibility and potential structure of a small claims patent court[5].

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,065,265

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Steriscience FOCINVEZ fosaprepitant dimeglumine SOLUTION;INTRAVENOUS 216686-001 Aug 22, 2023 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.